Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Launched by POTRERO MEDICAL · Dec 9, 2020

Keywords

ClinConnect Summary

The Accuryn Registry Study is a research project that aims to gather important health information from patients undergoing heart surgery. The study will use a special monitoring device called the Accuryn Monitoring System to track various health signals from these patients during their surgery and recovery in the intensive care unit (ICU). The goal is to better understand conditions like high pressure in the abdomen, kidney problems, and complications that can arise after heart surgery.

To participate in this study, patients must be at least 18 years old and have their heart surgery monitored using the Accuryn system. However, individuals with severe kidney disease or those in sensitive situations, like pregnant women or prisoners, may not be eligible. Participants will provide consent and will have their health data collected, which could help improve care for future patients undergoing similar procedures. This study is currently recruiting participants globally.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Signed or Verbal Informed Consent as required by IRB (if applicable).
• • 2. Adult (age ≥ 18).
• • 3. Monitored on the Accuryn® Monitoring System during their procedure and ICU stay (for retrospective enrollment).
• • 4. Patient is undergoing cardiac surgical intervention(s).
• Exclusion Criteria:
• • 1. Known history of advanced chronic kidney disease defined by an estimated glomerular filtration rate (eGFR) \<20 mL/min/1.73m2 within 30 days prior to procedure.
• • 2. The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as pregnant women, prisoners ,or those detained in a penal institution.